BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15897313)

  • 1. Single nucleotide polymorphisms in the gene encoding the major histocompatibility complex class II transactivator (CIITA) in systemic lupus erythematosus.
    Koizumi K; Okamoto H; Iikuni N; Nakamura T; Kawamoto M; Momohara S; Ichikawa N; Furuya T; Kotake S; Taniguchi A; Yamanaka H; Kamatani N
    Ann Rheum Dis; 2005 Jun; 64(6):947-50. PubMed ID: 15897313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA).
    Patarroyo JC; Stuve O; Piskurich JF; Hauser SL; Oksenberg JR; Zamvil SS
    Genes Immun; 2002 Feb; 3(1):34-7. PubMed ID: 11857059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polymorphic variant in the MHC2TA gene is not associated with systemic lupus erythematosus.
    Linga-Reddy MV; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Nordmark G; Rönnblom L; Alarcón-Riquelme ME
    Tissue Antigens; 2007 Nov; 70(5):412-4. PubMed ID: 17711409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism in MHC class II transactivator gene is not associated with susceptibility to colorectal cancer in Swedish patients.
    Mumtaz M; Löfgren S; Hugander A; Dimberg J
    Anticancer Res; 2008; 28(3B):1789-91. PubMed ID: 18630461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility.
    Kyogoku C; Dijstelbloem HM; Tsuchiya N; Hatta Y; Kato H; Yamaguchi A; Fukazawa T; Jansen MD; Hashimoto H; van de Winkel JG; Kallenberg CG; Tokunaga K
    Arthritis Rheum; 2002 May; 46(5):1242-54. PubMed ID: 12115230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major histocompatibility complex class II transactivator gene polymorphism: associations with Löfgren's syndrome.
    Grunewald J; Idali F; Kockum I; Seddighzadeh M; Nisell M; Eklund A; Padyukov L
    Tissue Antigens; 2010 Aug; 76(2):96-101. PubMed ID: 20230522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10 gene polymorphisms are associated with the SLICC/ACR Damage Index in systemic lupus erythematosus.
    Sung YK; Park BL; Shin HD; Kim LH; Kim SY; Bae SC
    Rheumatology (Oxford); 2006 Apr; 45(4):400-4. PubMed ID: 16287924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
    Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
    Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
    Geirsson A; Paliwal I; Lynch RJ; Bothwell AL; Hammond GL
    Transplantation; 2003 Jul; 76(2):387-94. PubMed ID: 12883198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA.
    Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Wong HK; Kammer GM; Tsokos GC
    Arthritis Rheum; 2001 Jun; 44(6):1336-50. PubMed ID: 11407693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel polymorphism of the human APRIL gene is associated with systemic lupus erythematosus.
    Koyama T; Tsukamoto H; Masumoto K; Himeji D; Hayashi K; Harada M; Horiuchi T
    Rheumatology (Oxford); 2003 Aug; 42(8):980-5. PubMed ID: 12730512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Not polymorphism but methylation of class II transactivator gene promoter IV associated with persistent HBV infection.
    He Y; Zhao Y; Zhang S; Chen W; Lin S; Yang Q; Liu J; Yang Y; Jin Y; Liu M
    J Clin Virol; 2006 Dec; 37(4):282-6. PubMed ID: 16996793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus.
    Kanemitsu S; Ihara K; Saifddin A; Otsuka T; Takeuchi T; Nagayama J; Kuwano M; Hara T
    J Rheumatol; 2002 Jun; 29(6):1183-8. PubMed ID: 12064832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans.
    Prokunina L; Castillejo-López C; Oberg F; Gunnarsson I; Berg L; Magnusson V; Brookes AJ; Tentler D; Kristjansdóttir H; Gröndal G; Bolstad AI; Svenungsson E; Lundberg I; Sturfelt G; Jönssen A; Truedsson L; Lima G; Alcocer-Varela J; Jonsson R; Gyllensten UB; Harley JB; Alarcón-Segovia D; Steinsson K; Alarcón-Riquelme ME
    Nat Genet; 2002 Dec; 32(4):666-9. PubMed ID: 12402038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphisms of deoxyribonuclease I and their expression in Chinese systemic lupus erythematosus patients.
    Feng XB; Shen N; Qian J; Sun L; Hua J; Chen SL
    Chin Med J (Engl); 2004 Nov; 117(11):1670-6. PubMed ID: 15569484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic modulation of RFC1, MHC2TA and HLA-DR in systemic lupus erythematosus: association with serological markers and six functional polymorphisms of one-carbon metabolic pathway.
    Rupasree Y; Naushad SM; Rajasekhar L; Kutala VK
    Gene; 2014 Feb; 536(1):45-52. PubMed ID: 24333266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
    Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
    J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of DNase IV polymorphisms with autoantibodies in patients with systemic lupus erythematosus.
    Kim I; Hur NW; Shin HD; Park BL; Cheong HS; Bae SC
    Rheumatology (Oxford); 2008 Jul; 47(7):996-9. PubMed ID: 18417526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New single nucleotide polymorphisms in the coding region of human TNFR2: association with systemic lupus erythematosus.
    Tsuchiya N; Komata T; Matsushita M; Ohashi J; Tokunaga K
    Genes Immun; 2000 Dec; 1(8):501-3. PubMed ID: 11197692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.